|
ANIX Anixa Biosciences Inc 715446 |
| Balance Sheet |
|
Current Assets
|
$14,911,000.00 |
|
Assets
|
$15,074,000.00 |
|
Current Liabilities
|
$1,745,000.00 |
|
Liabilities
|
$1,873,000.00 |
|
Equity
|
$14,471,000.00 |
|
Shares Out
|
34584538.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-6,121,000.00 |
|
Investing Cash Flow
|
$1,405,000.00 |
| Market Analysis |
Market Cap
|
$124,158,491.42 |
|
Price
|
$3.59 |
|
BVPS
|
0.42 |
|
PB
|
8.55 |
|
EPS
|
-0.08 |
|
PS
|
591.23 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:51 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:41 |
| Jan |
Feb |
Mar |
|
|
2026-01-12 |
-0.34 |
|
|
| Apr |
May |
Jun |
| 2026-03-09 |
-0.08 |
|
|
|
|
| Jul |
Aug |
Sep |
| 2026-06-10 |
-0.07 |
|
|
|
|
| Oct |
Nov |
Dec |
| 2025-09-10 |
-0.07 |
|
|
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ANIX documents filed with the SEC.
ANIX Filings
Clear